Literature DB >> 35190188

Dynorphin/Kappa Opioid Receptor Activity Within the Extended Amygdala Contributes to Stress-Enhanced Alcohol Drinking in Mice.

Harold L Haun1, Christina L Lebonville1, Matthew G Solomon1, William C Griffin1, Marcelo F Lopez1, Howard C Becker2.   

Abstract

BACKGROUND: While there is high comorbidity of stress-related disorders and alcohol use disorder, few effective treatments are available and elucidating underlying neurobiological mechanisms has been hampered by a general lack of reliable animal models. Here, we use a novel mouse model demonstrating robust and reproducible stress-enhanced alcohol drinking to examine the role of dynorphin/kappa opioid receptor (DYN/KOR) activity within the extended amygdala in mediating this stress-alcohol interaction.
METHODS: Mice received repeated weekly cycles of chronic intermittent ethanol exposure alternating with weekly drinking sessions ± forced swim stress exposure. Pdyn messenger RNA expression was measured in the central amygdala (CeA), and DYN-expressing CeA neurons were then targeted for chemogenetic inhibition. Finally, a KOR antagonist was microinjected into the CeA or bed nucleus of the stria terminalis to examine the role of KOR signaling in promoting stress-enhanced drinking.
RESULTS: Stress (forced swim stress) selectively increased alcohol drinking in mice with a history of chronic intermittent ethanol exposure, and this was accompanied by elevated Pdyn messenger RNA levels in the CeA. Targeted chemogenetic silencing of DYN-expressing CeA neurons blocked stress-enhanced drinking, and KOR antagonism in the CeA or bed nucleus of the stria terminalis significantly reduced stress-induced elevated alcohol consumption without altering moderate intake in control mice.
CONCLUSIONS: Using a novel and robust model of stress-enhanced alcohol drinking, a significant role for DYN/KOR activity within extended amygdala circuitry in mediating this effect was demonstrated, thereby providing further evidence that the DYN/KOR system may be a valuable target in the development of more effective treatments for individuals presenting with comorbidity of stress-related disorders and alcohol use disorder.
Copyright © 2022 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol; Amygdala; Bed nucleus of the stria terminalis; Dynorphin; Kappa opioid receptor; Stress

Mesh:

Substances:

Year:  2022        PMID: 35190188      PMCID: PMC9167153          DOI: 10.1016/j.biopsych.2022.01.002

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   12.810


  68 in total

1.  Effects of voluntary alcohol drinking on corticotropin-releasing factor and preprodynorphin mRNA levels in the central amygdala of Sardinian alcohol-preferring rats.

Authors:  Yan Zhou; Giancarlo Colombo; Gian Luigi Gessa; Mary Jeanne Kreek
Journal:  Neurosci Lett       Date:  2013-09-08       Impact factor: 3.046

Review 2.  Alcohol, stress, and glucocorticoids: From risk to dependence and relapse in alcohol use disorders.

Authors:  Sara K Blaine; Rajita Sinha
Journal:  Neuropharmacology       Date:  2017-02-01       Impact factor: 5.250

Review 3.  Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.

Authors:  Rachel I Anderson; Howard C Becker
Journal:  Alcohol Clin Exp Res       Date:  2017-06-05       Impact factor: 3.455

Review 4.  Stress and alcohol interactions: animal studies and clinical significance.

Authors:  Rainer Spanagel; Hamid R Noori; Markus Heilig
Journal:  Trends Neurosci       Date:  2014-03-11       Impact factor: 13.837

5.  Co-morbid anxiety disorders predict early relapse after inpatient alcohol treatment.

Authors:  A F A Schellekens; C A J de Jong; J K Buitelaar; R J Verkes
Journal:  Eur Psychiatry       Date:  2014-03-12       Impact factor: 5.361

6.  Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects.

Authors:  Stephen L Lowe; Conrad J Wong; Jennifer Witcher; Celedon R Gonzales; Gemma L Dickinson; Robert L Bell; Linda Rorick-Kehn; MaryAnn Weller; Randall R Stoltz; Jane Royalty; Sitra Tauscher-Wisniewski
Journal:  J Clin Pharmacol       Date:  2014-03-26       Impact factor: 3.126

7.  Maladaptive behavioral regulation in alcohol dependence: Role of kappa-opioid receptors in the bed nucleus of the stria terminalis.

Authors:  Chloe M Erikson; Gengze Wei; Brendan M Walker
Journal:  Neuropharmacology       Date:  2018-07-31       Impact factor: 5.250

Review 8.  The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.

Authors:  M R Bruchas; B B Land; C Chavkin
Journal:  Brain Res       Date:  2009-08-28       Impact factor: 3.252

9.  Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward.

Authors:  Ream Al-Hasani; Jordan G McCall; Gunchul Shin; Adrian M Gomez; Gavin P Schmitz; Julio M Bernardi; Chang-O Pyo; Sung Il Park; Catherine M Marcinkiewcz; Nicole A Crowley; Michael J Krashes; Bradford B Lowell; Thomas L Kash; John A Rogers; Michael R Bruchas
Journal:  Neuron       Date:  2015-09-02       Impact factor: 17.173

Review 10.  Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disorders.

Authors:  Hugo A Tejeda; Antonello Bonci
Journal:  Brain Res       Date:  2018-09-19       Impact factor: 3.252

View more
  1 in total

Review 1.  Interplay between the oxytocin and opioid systems in regulating social behaviour.

Authors:  Philip T Putnam; Steve W C Chang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2022-07-11       Impact factor: 6.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.